Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
59.36 USD | +2.54% | -9.07% | -28.90% |
May. 09 | Oppenheimer Adjusts Cytokinetics Price Target to $106 From $107, Maintains Outperform Rating | MT |
May. 08 | Cytokinetics Q1 Net Loss Narrows, Revenue Declines | MT |
MarketScreener Editorial Features
Today on Wall Street: Breaking record after record | August 13, 2021 at 09:05 am EDT |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- MarketScreener Editorial Features